Replies to post #483190 on BB's Stock Haven

[explorer186]

That or they buy RGEN out since it only has a $124 million market cap

[OTC BB King]

RGEN - could be a substantial lump sum payment for the patent or annual royalties based on sales of the product. The drug is projected to have a $1B market each year. The going rate for royalited is anywhere from 4-6% sales. The royalty payment could be in the range of $50-100M a year IMO. RGEN's current market cap is ONLY about $120M right now!